MERCK & CO, INC. for MERCK & CO INC
What was lobbied
7 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Non-interference in Medicare Part D (no specific bill), Medicaid-style rebates in Medicare Part D (no specific bill), Low-income subsidy co-pays in Part D (no specific bill), Independent Payment Advisory Board (S.351, H.R. 351), sustainable growth rate (H.R. 4302), Medicaid (no specific bill)
| Lobbyist | Covered position, as disclosed |
|---|---|
| ERIN DARLING | — |
| ROBERT FILIPPONE | — |
| ELI JOSEPH | — |
| JEROME MURRAY | — |
| KATIE OPPENHEIM | — |
| ERIN POLAK | — |
| ANGELA M STEWART | — |
Copyright/Patent/Trademark CPT
Patent reform (H.R. 3309, S.1720)
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT FILIPPONE | — |
| ELI JOSEPH | — |
| KATIE OPPENHEIM | — |
| ERIN POLAK | — |
| ANGELA M STEWART | — |
| JASON BENJAMIN VAN PELT | — |
Budget/Appropriations BUD
Deficit reduction (no specific bill)
| Lobbyist | Covered position, as disclosed |
|---|---|
| ERIN DARLING | — |
| ROBERT FILIPPONE | — |
| ELI JOSEPH | — |
| JEROME MURRAY | — |
| KATIE OPPENHEIM | — |
| ERIN POLAK | — |
| ANGELA M STEWART | — |
| JASON BENJAMIN VAN PELT | — |
Trade (domestic/foreign) TRD
Trans-Pacific Partnership (no specific bill), biologic data exclusivity (no specific bill), trade promotion authority (no specific bill), treatment of intellectual property in India (no specific bill), Playing Fair on Trade and Innovation Act (H.R. 3167), additives in beef cattle (no specific bill), trade adjustment assistance (no specific bill), international trade barriers for beta-agonists (no specific bill)
| Lobbyist | Covered position, as disclosed |
|---|---|
| JEROME MURRAY | — |
| ERIN POLAK | — |
| ANGELA M STEWART | — |
| JASON BENJAMIN VAN PELT | — |
Taxation/Internal Revenue Code TAX
Comprehensive tax reform (no specific bill), transfer pricing of intangibles (no specific bill), territorial tax system (no specific bill), deferral of taxation of foreign earned income (no specific bill), tax base erosion (no specific bill), orphan drug tax credit (S.1128), R&D tax credit (no specific bill)
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT FILIPPONE | — |
| ELI JOSEPH | — |
| JEROME MURRAY | — |
| KATIE OPPENHEIM | — |
| ERIN POLAK | — |
| ANGELA M STEWART | — |
| JASON BENJAMIN VAN PELT | — |
Health Issues HCR
Alzheimer's education (no specific bill), 340B (no specific bill), National Diabetes Clinical Care Commission Act (H.R. 1074, S.539), Eliminating Disparities in Diabetes Prevention Act (H.R. 3322), Oncology education (no specific bill), adult vaccine policies (no specific bill), medication adherence, DISARM (H.R. 4187), ACA Implementation (no specific bill), Hepatitis C education (no specific bill), general pharmaceutical industry education, OTC medicines - dextromethorpan and pseudoephedrine (no specific bill).
| Lobbyist | Covered position, as disclosed |
|---|---|
| ERIN DARLING | — |
| ROBERT FILIPPONE | — |
| ELI JOSEPH | — |
| PATRICK LIEDTKA | — |
| JEROME MURRAY | — |
| KATIE OPPENHEIM | — |
| ERIN POLAK | — |
| ANGELA M STEWART | — |
| JASON BENJAMIN VAN PELT | — |
Animals ANI
Education on beta-agonists (no specific bill)
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELI JOSEPH | — |
| KATIE OPPENHEIM | — |
| ERIN POLAK | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.